SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-027013
Filing Date
2022-02-03
Accepted
2022-02-03 16:16:00
Documents
1
Group Members
LSP V MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d304718dsc13da.htm SC 13D/A 48838
  Complete submission text file 0001193125-22-027013.txt   50655
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-56243 | Film No.: 22588486
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV
Business Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV 31-20-664-5500
LSP V Cooperatieve U.A. (Filed by) CIK: 0001726006 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7
Type: SC 13D/A